Ken Dower

Ken Dower is a PhD Scientist and Research Fellow at Pfizer, specializing in molecular and cell biology, inflammation, and fibrosis. With 10 years of experience in the pharmaceutical industry, Ken has held various leadership roles, including Fibrosis Group Head, where they manage a team and oversee fibrosis target identification and validation. Previously, Ken worked at Harvard Medical School as a Research Associate and has served as a post-doctoral fellow and principal scientist at Pfizer, focusing on innate immunity and autoimmune diseases. Ken's academic background includes a BA and BS from the University of California, Berkeley, and a PhD from Brandeis University.